Assessment of Knee Flexor Muscles Strength in Patients With Patellar Instability

NCT04838158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2021-04-08

No results posted yet for this study

Summary

The study enrolled 33 patients with confirmed recurrent patellar dislocation, including 6 patients with bilateral involvement. In the study group, both side hamstring muscle were evaluated at the velocities of 60 and 180 deg/s for the following parameters: peak torque, torque in 30 degree of the knee flexion, angle of peak torque and peak torque hamstring to quadriceps ratio (H/Q ratio).

Conditions

  • Patella Dislocation Recurrent
  • Children, Only

Interventions

DIAGNOSTIC_TEST

Isokinetic measurements

Each patient underwent an isokinetic examination on Biodex System 3 (Biodex Multi-Joint System - Pro, Biodex Medical Systems, Inc. New York, USA). In the study group, both side hamstring muscle were evaluated at the velocities of 60 and180 deg/s for the following parameters: peak torque (PT), torque in 30 degree of the knee flexion (T 30 deg.), angle of peak torque (APT) and peak torque hamstring to quadriceps ratio (H/Q ratio).

Sponsors & Collaborators

  • Polish Mother Memorial Hospital Research Institute

    lead OTHER

Principal Investigators

  • Krzysztof Małecki, Ph.D. · Polish Mother's Memorial Hospital Research Institute

  • Jarosław Fabiś, prof. · Medical University of Lodz

  • Paweł Flont, Ph.D. · Polish Mother's Memorial Hospital Research Institute

  • Anna Fabiś-Strobin, Ph.D. · Polish Mother's Memorial Hospital Research Institute

  • Kryspin Niedzielski, prof. · Polish Mother's Memorial Hospital Research Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-10
Primary Completion
2016-01-30
Completion
2016-01-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04838158 on ClinicalTrials.gov